 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| . |  |
. |
Failed AIDS vaccine may have increased infection risk
Chicago (AFP) Nov 7, 2007 A once-promising vaccine for AIDS may have inadvertently increased the infection risk of people participating in clinical trials, researchers said Wednesday. The multinational trials involving more than 3,000 HIV-negative volunteers were cancelled in September after a large-scale study found it was not effective at preventing infection. Further analysis showed that those who received the vaccine had a higher rate of infection than those who received a placebo, said US pharmaceutical giant Merck, which helped develop the vaccine. The study volunteers who received the vaccine are being advised of their potentially increased susceptibility, Merck said. "We are analyzing the data to try to determine if the results are due to immune responses induced by the vaccine, differences in study populations, or some other biological phenomenon we don't yet understand, or simply due to chance," said Keith Gottesdiener, vice president of Merck's vaccine and infectious disease clinical research. "It will take some time before we understand why the vaccine did not work and why there was a trend toward more cases of infection in volunteers who received the vaccine," he said in a statement. The experimental vaccine cannot cause infection, Merck said. It was a modified cold virus used to deliver three synthetically produced HIV genes in the hopes of stimulating a response from the immune system. The randomized, double-blind trials were conducted in various sites in North America, South America, the Caribbean, Australia and South Africa. All but one of the infections were in male volunteers and the bulk of those infected were homosexual men. Community Email This Article Comment On This Article Related Links Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
NASA Technology Helps Predict And Prevent Future Pandemic Outbreaks
Washington DC (SPX) Nov 07, 2007With the help of 14 satellites currently in orbit and the National Aeronautics and Space Administration's (NASA) Applied Sciences Program, scientists have been able to observe the Earth's environment to help predict and prevent infectious disease outbreaks around the world. The use of remote sensing technology aids specialists in predicting the outbreak of some of the most common and deadly infectious diseases today such as Ebola, West Nile virus and Rift Valley Fever. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2007 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
